Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Chronic Kidney Disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-08-20; most recent amendment 2025-04-14.
Trial Details
NCT Number NCT05018845
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Chronic Kidney Diseases
Enrollment 20 participants
Start Date 2021-11-06
Primary Completion 2025-11 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-04-17